Fingerprint
Dive into the research topics of 'A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically